{
    "id": 25404,
    "fullName": "FLT4 positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "FLT4 (VEGFR3) positive indicates the presence of the FLT4 (VEGFR3) gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 2324,
        "geneSymbol": "FLT4",
        "terms": [
            "FLT4",
            "CHTD7",
            "FLT-4",
            "FLT41",
            "LMPH1A",
            "LMPHM1",
            "PCL",
            "VEGFR-3",
            "VEGFR3"
        ]
    },
    "variant": "positive",
    "createDate": "09/18/2016",
    "updateDate": "04/25/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 8415,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Lenvima (lenvatinib) inhibited interaction between colorectal cancer cells positive for Flt1 (Vegfr1), KDR (VEGFR2), and FLT4 (Vegfr3) and endothelial cells in culture, resulted in inhibition of angiogenesis and delayed tumor growth in cell line xenograft models (PMID: 25425971).",
            "molecularProfile": {
                "id": 26314,
                "profileName": "FLT1 pos FLT4 pos KDR pos"
            },
            "therapy": {
                "id": 792,
                "therapyName": "Lenvatinib",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6642,
                    "pubMedId": 25425971,
                    "title": "E7080 (lenvatinib), a multi-targeted tyrosine kinase inhibitor, demonstrates antitumor activities against colorectal cancer xenografts.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25425971"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26314,
            "profileName": "FLT1 pos FLT4 pos KDR pos",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 26315,
            "profileName": "FLT4 positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}